Atrial fibrillation and flutter outcomes and risk determination (AFFORD): Design and rationale

Journal of Cardiology

Volumn 58, Issue 2, 2011, Pages 124-130

  Barrett, Tyler W ^a   Storrow, Alan B ^a   Jenkins, Cathy A ^b   Harrell, Frank E ^b   Miller, Karen F ^a   Moser, Kelly M ^a   Russ, Stephan ^a   Roden, Dan M ^a,b   Darbar, Dawood ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Atrial flutter; Emergency care; Prognosis

Indexed keywords

ARTICLE; CARDIAC PATIENT; CLINICAL EXAMINATION; COHORT ANALYSIS; DISEASE COURSE; DISEASE EXACERBATION; EMERGENCY WARD; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; LABORATORY TEST; MEDICAL HISTORY; OBSERVATIONAL STUDY; PROGNOSIS; RISK ASSESSMENT;

ADULT; ATRIAL FIBRILLATION; ATRIAL FLUTTER; COHORT STUDIES; DISEASE MANAGEMENT; EMERGENCY SERVICE, HOSPITAL; FEMALE; FORECASTING; HUMANS; INCIDENCE; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME;

EID: 80052024838     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2011.06.007     Document Type: Article

References (36)

1. Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., Singer D.E. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) Study. JAMA 2001, 285:2370-2375.
2. Inoue H., Fujiki A., Origasa H., Ogawa S., Okumura K., Kubota I., Aizawa Y., Yamashita T., Atarashi H., Horie M., Ohe T., Doi Y., Shimizu A., Chishaki A., Saikawa T., et al. Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination. Int J Cardiol 2009, 137:102-107.
3. Benjamin E.J., Wolf P.A., D'Agostino R.B., Silbershatz H., Kannel W.B., Levy D. Impact of atrial fibrillation on the risk of death: the Framingham heart study. Circulation 1998, 98:946-952.
4. Atarashi H., Inoue H., Okumura K., Yamashita T., Origasa H. J-RHYTHM registry investigators. Investigation of optimal anticoagulation strategy for stroke prevention in Japanese patients with atrial fibrillation - the J-RHYTHM registry study design. J Cardiol 2011, 57:95-99.
5. Stewart S., Hart C.L., Hole D.J., McMurray J.J. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002, 113:359-364.
6. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991, 22:983-988.
7. Scott P.A., Pancioli A.M., Davis L.A., Frederiksen S.M., Eckman J. Prevalence of atrial fibrillation and antithrombotic prophylaxis in emergency department patients. Stroke 2002, 33:2664-2669.
8. Coyne K.S., Paramore C., Grandy S., Mercader M., Reynolds M., Zimetbaum P. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health 2006, 9:348-356.
9. Kim M.H., Johnston S.S., Chu B.C., Dalal M.R., Schulman K.L. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes 2011, 4:313-320.
10. Stiell I., Clement C.M., Brison R.J., Rowe B.H., Borgundvaag B., Langhan T., Lang E., Magee K., Stenstrom R., Perry J.J., Birnie D., Wells G.A. Variation in management of recent-onset atrial fibrillation and flutter among academic hospital emergency departments. Ann Emerg Med 2011, 57:13-21.
11. Zimetbaum P., Reynolds M.R., Ho K.K., Gaziano T., McDonald M.J., McClennen S., Berezin R., Josephson M.E., Cohen D.J. Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs. Am J Cardiol 2003, 92:677-681.
12. Decker W.W., Smars P.A., Vaidyanathan L., Goyal D.G., Boie E.T., Stead L.G., Packer D.L., Meloy T.D., Boggust A.J., Haro L.H., Laudon D.A., Lobi J.K., Sadosty A.T., Schears R.M., Schiebel N.E., et al. A prospective, randomized trial of an emergency department observation unit for acute onset atrial fibrillation. Ann Emerg Med 2008, 52:322-328.
13. Koenig B.O., Ross M.A., Jackson R.E. An emergency department observation unit protocol for acute-onset atrial fibrillation is feasible. Ann Emerg Med 2002, 39:374-381.
14. Stiell I.G., Clement C.M., Symington C., Perry J.J., Vaillancourt C., Wells G.A. Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter. Acad Emerg Med 2007, 14:1158-1164.
15. McDonald A.J., Pelletier A.J., Ellinor P.T., Camargo C.A. Increasing U.S. emergency department visit rates and subsequent hospital admissions for atrial fibrillation from 1993 to 2004. Ann Emerg Med 2008, 51:58-65.
16. Barrett T.W., Martin A.R., Storrow A.B., Jenkins C.A., Harrell F.E., Russ S., Roden D.M., Darbar D. A clinical prediction model to estimate risk for thirty day adverse events in emergency department patients with symptomatic atrial fibrillation. Ann Emerg Med 2011, 57:1-12.
17. Harrell F.E., Lee K.L., Califf R.M., Prtor D.B., Rosati R.A. Regression modelling strategies for improved prognostic prediction. Stat Med 1984, 3:143-152.
18. Harrell F.E., Lee K.L., Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15:361-387.
19. Harrell F.E., Margolis P.A., Gove S., Mason K.E., Mulholland E.K., Lehmann D., Muhe L., Gatchalian S., Eichenwald H.F. Development of a clinical prediction model for an ordinal outcome: the World Health Organization Multicentre Study of clinical signs and etiological agents of pneumonia, sepsis and meningitis in young infants WHO/ARI Young Infant Multicentre Study group. Stat Med 1998, 17:909-944.
20. Laupacis A., Sekar N., Stiell I.G. Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA 1997, 277:488-494.
21. Steyerberg E.W., Eijkemans M.J., Harrell F.E., Habbema J.D. Prognostic modeling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med 2000, 19:1059-1079.
22. Steyerberg E.W., Harrell F.E., Borsboom G.J., Eijkemans M.J., Vergouwe Y., Habbema J.D. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001, 54:774-781.
23. Estes N.A., Halperin J.L., Calkins H., Ezekowitz M.D., Gitman P., Go A.S., McNamara R.L., Messer J.V., Ritchie J.L., Romeo S.J., Waldo A.L., Wyse D.G. ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation): developed in collaboration with the Heart Rhythm Society. Circulation 2008, 117:1101-1120.
24. Fuster V., Ryden L.E., Asinger R.W., Cannom D.S., Crijns H.J., Frye R.L., Halperin J.L., Kay G.N., Klein W.W., Levy S., McNamara R.L., Prystowsky E.N., Wann L.S., Wyse D.G., Gibbons R.J., et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary, A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 2001, 38:1231-1266.
25. Fuster V., Ryden L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., Halperin J.L., Le Heuzey J.Y., Kay G.N., Lowe J.E., Olsson S.B., Prystowsky E.N., Tamargo J.L., Wann S., Smith SC, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). J Am Coll Cardiol 2006, 48:854-906.
26. Gilbert E.H., Lowenstein S.R., Koziol-McLain J., Barta D.C., Steiner J. Chart reviews in emergency medicine research: where are the methods?. Ann Emerg Med 1996, 27:305-308.
27. Steyerberg E.W. Clinical prediction models - a practical approach to development, validation, and updating 2009, Springer, New York.
28. Shigematsu Y., Hamada M., Nagai T., Nishimura K., Inoue K., Suzuki J., Ogimoto A., Higaki J. Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy: association with insulin resistance. J Cardiol 2011, April 22 [Epub ahead of print].
29. Lee Y.S., Hyun D.W., Jung B.C., Cho Y.K., Lee S.H., Shin D.G., Park H.S., Han S.W., Kim Y.N. Left atrial volume index as a predictor for occurrence of atrial fibrillation after ablation of typical atrial flutter. J Cardiol 2010, 56:348-353.
30. Maehama T., Okura H., Imai K., Saito K., Yamada R., Koyama T., Hayashida A., Neishi Y., Kawamoto T., Yoshida K. Systemic inflammation and left atrial thrombus in patients with non-rheumatic atrial fibrillation. J Cardiol 2010, 56:118-124.
31. Ichiki H., Orihara K., Hamasaki S., Ishida S., Oketani N., Iriki Y., Ninomiya Y., Okui H., Kuwahata S., Fujita S., Matsushita T., Yoshifuku S., Oba R., Hirai H., Nagata K., et al. The role of infection in the development of non-valvular atrial fibrillation: up-regulation of Toll-like receptor 2 expression levels on monocytes. J Cardiol 2009, 53:127-135.
32. Baba O., Izuhara M., Kadota S., Mitsuoka H., Shioji K., Uegaito T., Mutsuo S., Matsuda M. Determinant factors of plasma B-type natriuretic peptide levels in patients with persistent nonvalvular atrial fibrillation and preserved left ventricular systolic function. J Cardiol 2009, 4:402-408.
33. McGinn T.G., Guyatt G.H., Wyer P.C., Naylor C.D., Stiell I.G., Richardson W.S. Users' guides to the medical literature: XXII: how to use articles about clinical decision rules, Evidence-Based Medicine Working Group. JAMA 2000, 284:79-84.
34. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis 2001, Springer, New York. F.E. Harrell (Ed.).
35. Donders A.R., van der Heijden G.J., Stijnen T., Moons K.G. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol 2006, 59:1087-1091.
36. McCullagh P. Regression models for ordinal data (with discussion). J R Stat Soc, Series B 1980, 42:109-142.